No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DSS DSS Inc
- 1.5500
- -0.0596-3.70%
Close Jun 18 16:00 ET
10.95MMarket Cap-141P/E (TTM)
1.6300High1.5500Low7.75KVolume1.6100Open1.6096Pre Close12.38KTurnover0.27%Turnover RatioLossP/E (Static)7.07MShares9.360052wk High0.18P/B4.45MFloat Cap1.400052wk Low--Dividend TTM2.87MShs Float331917.1514Historical High--Div YieldTTM4.97%Amplitude1.4000Historical Low1.5970Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
DSS Unit Impact Biomedical Sets Terms for Downsized $6M IPO
DSS Unit Impact BioMedical Reduces Planned IPO Size to 1.5M Shrs From 2M, Still Expects Price Between $3 and $5 Each
DSS Unit Impact BioMedical Reduces Planned IPO Size to 1.5M Shrs From 2M, Still Expects Price Between $3 and $5 Each
DSS Inc | 10-Q: Quarterly report
DSS and PRPL Among Consumer Discretionary Movers
Express News | Impact Biomedical Announces U.S. Patent Allowance Of Laetose Technology Titled "Low Glycemic Sugar Composition"
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose Technology Entitled "Low Glycemic Sugar Composition."
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE:DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose technology
Comments
$DSS Inc(DSS.US$ I know some have suggested that the SEC will do nothing about this. I think it might be a good idea to call the Ombudsman of the SEC, Stacey Puente at her direct number which is 202-551-3330.
$Alset(40V.SG$ $DSS Inc(DSS.US$
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
https://www.globenewswire.com/en/news-release/2023/11/28/2786916/0/en/Premier-Packaging-a-Wholly-Owned-Subsidiary-of-DSS-Inc-Secures-Contract-Extension-with-Major-Retailer-Worth-Up-to-15-Million-over-Four-Years.html
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
https://www.globenewswire.com/en/news-release/2023/11/28/2786916/0/en/Premier-Packaging-a-Wholly-Owned-Subsidiary-of-DSS-Inc-Secures-Contract-Extension-with-Major-Retailer-Worth-Up-to-15-Million-over-Four-Years.html
CEO of DSS, Inc., Frank Heuszel, values the conversion of DBH's equity interest into preferred stock, benefiting Impact's existing shareholders and DSS shareholders who obtained Impact shares via a dividend distribution.
1
$Alset(40V.SG$ $DSS Inc(DSS.US$ $Alset(AEI.US$
Biomedical technology developer Impact BioMedical files for a $15 million IPO
https://www.renaissancecapital.com/IPO-Center/News/101440/Biomedical-technology-developer-Impact-BioMedical-files-for-a-$15-million-I
Biomedical technology developer Impact BioMedical files for a $15 million IPO
https://www.renaissancecapital.com/IPO-Center/News/101440/Biomedical-technology-developer-Impact-BioMedical-files-for-a-$15-million-I
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg